ANTIPROLIFERATIVE EFFECTS OF CYCLOCREATINE ON HUMAN PROSTATIC-CARCINOMA CELLS

Citation
Nm. Hoosein et al., ANTIPROLIFERATIVE EFFECTS OF CYCLOCREATINE ON HUMAN PROSTATIC-CARCINOMA CELLS, Anticancer research, 15(4), 1995, pp. 1339-1342
Citations number
13
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
15
Issue
4
Year of publication
1995
Pages
1339 - 1342
Database
ISI
SICI code
0250-7005(1995)15:4<1339:AEOCOH>2.0.ZU;2-0
Abstract
Creatine kinase (CK; EC 2.7.3.2) isoenzymes and their substrates have an important function in cellular energy generation. and utilization. The brain isoform (CK-BB) has been implicated in cellular transformati on processes involving the oncogenic products of the Ela virus and the p53 tumor suppressor gene. Cyclocreatine, an analogue of creatine, ha s been previously shown to inhibit the growth of a broad spectrum of c ancer cells derived from solid tumors. Results reported herein indicat e an increased level of creatine kinase activity in human prostate car cinoma cell lines and inhibitory effects of cyclocreatine alone and in combination with adriamycin on the growth of these cells in vitro and in vivo, in immune-deprived mice. Our results suggest the possible us e of cyclocreatine in the treatment of prostatic carcinoma.